FDA NDC Directory · JSON-LD · Markdown

Clobazam

NDC 59651-401 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA214404
Dosage form / routeSUSPENSION · ORAL
Active ingredientsCLOBAZAM (2.5 mg/mL)
Marketing started20220324
Package count1

External sources

Source: openFDA. Public-domain (CC0).